메뉴 건너뛰기




Volumn 52, Issue 5, 2002, Pages 1360-1366

Does escalation of the apical dose change treatment outcome in β-radiation of posterior choroidal melanomas with 106Ru plaques?

Author keywords

Brachytherapy; Choroidal melanoma; Ruthenium plaque radiotherapy; Uveal melanoma

Indexed keywords

DOSIMETRY; ONCOLOGY; PATIENT TREATMENT; RUTHENIUM; TUMORS;

EID: 0036535560     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)02763-8     Document Type: Article
Times cited : (15)

References (21)
  • 4
    • 0032786595 scopus 로고    scopus 로고
    • Long-term survival after ruthenium plaque radiotherapy for uveal melanoma; A meta-analysis of studies including 1066 patients
    • (1999) Acta Ophthalmol Scand , vol.77 , pp. 414-417
    • Seregard, S.1
  • 13
    • 2042436529 scopus 로고    scopus 로고
    • Sobin LH, Wittekind C, editors, for the International Union Against Cancer. TNM classification of malignant tumors. 5th ed. New York: Wiley-Liss; 1997.
  • 15
    • 0029157661 scopus 로고
    • Bilan de dix années d'experience de la beta-curiethérapie de contact par applicateur de ruthénium 106 pour mélanome de l'uvée; Revenue de 207 cas et hommage á P.K. Lommatzsch
    • (1995) Ophthalmologie , vol.9 , pp. 317-323
    • Grange, J.D.1    Joshi, G.2    Gérard, J.P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.